Applied Therapeutics, Inc. — Director's Dealing 2022

Jun 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2022-06-03

Reporting Person: MARCUS JOEL S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-03	Stock Option (Right to Buy)	$1.22	A	16500	Acquired	2032-06-02	Common Stock (16500)	Direct

Footnotes

F1: Consists of Options granted to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.